Hepatocellular carcinoma: overcoming challenges in disease management.
暂无分享,去创建一个
[1] R O Morgan,et al. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study , 2005, Gut.
[2] Hideyuki Shimizu,et al. Usefulness of measurement of lens culinaris agglutinin-reactive fraction of α-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma , 1999, American Journal of Gastroenterology.
[3] S. Ryder. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults , 2003, Gut.
[4] I. Yasuda,et al. Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma , 2005, Intervirology.
[5] E. Abdalla,et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] G. Ferraioli,et al. Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center. , 2005, AJR. American journal of roentgenology.
[7] W. Rilling,et al. Multidisciplinary management of hepatocellular carcinoma. , 2002, Journal of vascular and interventional radiology : JVIR.
[8] J. Galmiche,et al. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case–control study with cost analysis , 2002, Alimentary pharmacology & therapeutics.
[9] K. McGlynn,et al. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. , 2004, Gastroenterology.
[10] V. Usatoff,et al. Resection of hepatocellular carcinoma. , 2001, Hepato-gastroenterology.
[11] J. Llovet,et al. Non-surgical therapies of hepatocellular carcinoma. , 2005, European journal of gastroenterology & hepatology.
[12] T. Asahara,et al. Hepatic arterial infusion of 5‐fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein , 2002, Journal of surgical oncology.
[13] J. Bruix,et al. Prognostic prediction and treatment strategy in hepatocellular carcinoma , 2002, Hepatology.
[14] F. X. Bosch,et al. Epidemiology of hepatocellular carcinoma. , 2005, Clinics in liver disease.
[15] G. D’Amico,et al. Meta-analysis as a source of evidence in gastroenterology: a critical approach. , 1999, Italian journal of gastroenterology and hepatology.
[16] M. Serra,et al. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis , 1998, Journal of Cancer Research and Clinical Oncology.
[17] E. Keeffe,et al. Racial differences in effectiveness of α‐fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis , 2002, Hepatology.
[18] O. Farges,et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. , 2002, Hepato-gastroenterology.
[19] A. Andriulli,et al. Pattern Analysis of Serum alpha-fetoprotein in the Early Diagnosis of Hepatocellular Carcinoma in Liver Cirrhosis , 1988, The International journal of biological markers.
[20] A. Zhu,et al. Hepatocellular carcinoma: the need for progress. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] A. Forbes,et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition , 2003, Gut.
[22] K. McGlynn,et al. The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update , 2003, Annals of Internal Medicine.
[23] L. Seeff. Introduction: The burden of hepatocellular carcinoma. , 2004, Gastroenterology.
[24] V. Chen,et al. Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis , 2003, American Journal of Gastroenterology.
[25] J. Bruix,et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma , 2004, Hepatology.
[26] V. Sriuranpong,et al. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. , 1998, American journal of clinical oncology.
[27] M. Pompili,et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre , 2005, Gut.
[28] S. Wallace,et al. Fine-needle aspiration biopsy of the liver. , 1980, AJR. American journal of roentgenology.
[29] A. D. Di Bisceglie,et al. Clinical presentation and natural course of hepatocellular carcinoma. , 2005, European journal of gastroenterology & hepatology.
[30] W. Jarnagin,et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. , 1999, Annals of surgery.
[31] R. Wiesner,et al. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. , 2004, Gastroenterology.
[32] M. Sherman,et al. Needle tract seeding after radiofrequency ablation of hepatic tumors. , 2005, Journal of vascular and interventional radiology : JVIR.
[33] J. Furui,et al. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. , 2002, Surgery.
[34] M. Sherman,et al. Screening for hepatocellular carcinoma , 1998, Hepatology.
[35] H. D’Agostino,et al. Percutaneous ablation therapy for hepatocellular carcinomas. , 1995, AJR. American journal of roentgenology.
[36] W. Yeo,et al. Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial , 1999, The Lancet.
[37] M. Cottone,et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. , 1994, Journal of hepatology.
[38] P. Tangkijvanich,et al. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. , 2004, World journal of gastroenterology.
[39] K. Reddy,et al. Management of hepatitis C virus in special populations: patient and treatment considerations. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[40] J. Bruix,et al. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.
[41] H. Blum,et al. Pathogenesis of hepatocellular carcinoma. , 2005, European journal of gastroenterology & hepatology.
[42] H. Moriwaki,et al. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. , 1999, The New England journal of medicine.
[43] H. El‐Serag,et al. Epidemiology of hepatocellular carcinoma. , 2001, Clinics in liver disease.
[44] John Wong,et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.
[45] Jeffrey W. Clark,et al. A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma , 2002, Cancer.
[46] T. Morgan,et al. Alcohol and hepatocellular carcinoma. , 2004, Gastroenterology.
[47] D. Guyader,et al. Prospective randomized trial of chemoembolization versus intra‐arterial injection of 131I‐labeled–iodized oil in the treatment of hepatocellular carcinoma , 1997, Hepatology.
[48] S. Fagan,et al. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. , 2004, American journal of surgery.
[49] S. Arii,et al. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. , 2001, Journal of hepato-biliary-pancreatic surgery.
[50] J. Bruel,et al. [Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients]. , 1999, Gastroenterologie clinique et biologique.
[51] V. Vilgrain,et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. , 2001, Journal of hepatology.
[52] R. Poon,et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. , 1999, Annals of surgery.
[53] M. Sherman. Pathogenesis and screening for hepatocellular carcinoma. , 2004, Clinics in liver disease.
[54] Yi‐Hsiang Huang,et al. Percutaneous Ablation Therapy for Hepatocellular Carcinoma: Current Practice and Future Perspectives , 2005, Journal of the Chinese Medical Association : JCMA.
[55] Lau Wy. Management of hepatocellular carcinoma. , 2002, Journal of the Royal College of Surgeons of Edinburgh.
[56] A. Wee. Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma , 2005, CytoJournal.
[57] H. Petrowsky,et al. Surgical therapy of hepatocellular carcinoma , 2005, European journal of gastroenterology & hepatology.
[58] M. Mihara,et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. , 2000, Journal of the American College of Surgeons.
[59] C. Bartolozzi,et al. Small Hepatocellular Carcinoma , 1996, Acta radiologica.
[60] Yasuo Ohashi,et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial , 2000, The Lancet.
[61] J. Bruix,et al. Prognosis of hepatocellular carcinoma. , 2002, Hepato-gastroenterology.
[62] H. Bismuth,et al. Liver Transplantation for Hepatocellular Carcinoma , 1999, Seminars in liver disease.
[63] L Pagliaro,et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.
[64] H. Hsu,et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. , 1985, Gastroenterology.
[65] T. Davern,et al. Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention‐to‐treat principle and dropout from the waiting list , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[66] M. Roncalli,et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. , 1995, Gastroenterology.
[67] P. Clavien,et al. Critical evaluation of the different staging systems for hepatocellular carcinoma , 2004, The British journal of surgery.
[68] S. Thorgeirsson,et al. Genetic profiling of human hepatocellular carcinoma. , 2005, Seminars in liver disease.
[69] J. Ogunbiyi. Hepatocellular carcinoma in the developing world. , 2001, Seminars in oncology.
[70] J. Marrero,et al. Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort , 2005, Hepatology.
[71] Y. Guan,et al. Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT. , 2005, World journal of gastroenterology.
[72] E. Barnes,et al. The surveillance and diagnosis of hepatocellular carcinoma. , 2005, European journal of gastroenterology & hepatology.